Regorafenib activates oxidative stress by inhibiting SELENOS and potentiates oxaliplatin-induced cell death in colon cancer cells.
Yu Y, Wu T, Zhang X, Li P, Ye L, Kuang J, Tao L, Ni L, Zhao Q, Zhang J, Pan H, Xie C, Zheng C, Li S, Cui R.
Yu Y, et al. Among authors: li s, li p.
Eur J Pharmacol. 2023 Oct 15;957:175986. doi: 10.1016/j.ejphar.2023.175986. Epub 2023 Aug 19.
Eur J Pharmacol. 2023.
PMID: 37598924